Plain-English translation of NCT06972056 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Migraine research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether three different migraine prevention medications — atogepant, propranolol, and topiramate — work equally well, or if one is better than the others for reducing how often you get migraines. Researchers want to understand which medication helps the most people cut their migraine days in half or more. You would be randomly assigned to take one of these medications for 12 weeks and track your migraines daily to help answer this question.
Migraine is a common and disabling condition, but doctors aren't always sure which prevention medication works best for which patients. This study will help doctors and patients understand which of these three treatments is most effective, so future patients can get the right medication faster.
You likely qualify if…
You likely don't qualify if…
You would start by filling out a daily headache diary for four weeks to confirm you qualify. If you do, you'll be randomly assigned to take one of the three medications and continue your daily diary during 12 weeks of treatment. You'll have research visits at the start, after four weeks, and then at weeks 4, 8, 12, 24, and 48 after beginning your assigned medication. The entire study lasts about a year, and you'll track how many moderate to severe headache days you have each month to see if the medication helps reduce them.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States